Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
AMGEN TO HOST WEBCAST TO DISCUSS MARITIDE PHASE 2 RESULTS AND PROGRESS ON DEVELOPMENT PROGRAM
07:00am, Tuesday, 26'th Nov 2024
THOUSAND OAKS, Calif. , Nov. 26, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcasted call for the investment community at 5 a.m.
Why Amgen (AMGN) is a Top Value Stock for the Long-Term
10:45am, Friday, 22'nd Nov 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investing in Pharma Stocks? Check These 3 Things First
09:15am, Friday, 22'nd Nov 2024
Investing in Pharma Stocks? Check These 3 Things First
Wall Street awaits Amgen weight-loss drug data expected to move shares
06:14am, Thursday, 21'st Nov 2024
Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might measure up against the popular GLP-1 drugs sold by Eli Lilly and Novo Nordis
AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
04:00pm, Wednesday, 20'th Nov 2024
Howard Chang, M.D., Ph.D., Joins as Senior Vice President of Research and Chief Scientific Officer THOUSAND OAKS, Calif.
Amgen Sells Off: Keep Calm And Buy The Dip
02:42pm, Monday, 18'th Nov 2024
Amgen's stock dropped nearly 15% last week due to safety concerns about its GLP-1 candidate MariTide. Amgen's management and analysts downplayed the bone mineral density concerns, emphasizing MariTide
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
10:05am, Monday, 18'th Nov 2024
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious
08:45am, Saturday, 16'th Nov 2024
Its future is bright, but that doesn't mean it'll always be smooth sailing.
NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Amgen Inc. (NASDAQ: AMGN) on b
Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate
04:00pm, Thursday, 14'th Nov 2024
AMGN says there was no connection between the administration of MariTide and bone mineral density changes.
AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024
04:00pm, Thursday, 14'th Nov 2024
MITIGATE Phase 3 Study Results Reinforce Promise of UPLIZNA® as the First Potential Treatment tor IgG4-RD Phase 4 AGILE Data Support Shortening KRYSTEXXA® Infusion Time THOUSAND OAKS, Calif. , Nov.
2 Dividend Stocks to Buy Hand Over Fist in November
10:15am, Thursday, 14'th Nov 2024
These companies have solid businesses and excellent dividend growth track records.
Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript)
04:19pm, Wednesday, 13'th Nov 2024
Amgen Inc. (NASDAQ:AMGN ) UBS Global Healthcare Conference November 13, 2024 1:15 PM ET Company Participants Peter Griffith - CFO Narimon Honarpour - SVP, Global Development Justin Claeys - VP, IR Con
Amgen initiated with a Neutral at Citi
04:12pm, Wednesday, 13'th Nov 2024
Citi initiated coverage of Amgen with a Neutral rating and $335 price target. The company's growth picture hinges on MariTide clinical success and to a lesser degree, the trajectory for several newer
Signal Says Pharma Stock Selloff Should Be Over
03:30pm, Wednesday, 13'th Nov 2024
Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday, following reports that the company's weight-loss drug, MariTide, triggers a si
